Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prospects and challenges of CAR-T cell therapy combined with ICIs
Yufan Lv, Xinyu Luo, Zhuoyi Xie, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 16

Showing 16 citing articles:

Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 5
Advances in Cell and Immune Therapies for Melanoma
Tanase Timis, Sanda Buruiana, Delia Dima, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 98-98
Open Access
From Biology to Clinical Practice: The Bone Marrow Microenvironment in Multiple Myeloma
Despina Fotiou, Eirini Katodritou
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 327-327
Open Access
Targeting refractory diffuse large B cell lymphoma by CAR-WEE1 T-cells: In vitro evaluation
Hadeer Mohamed Ahmed, Said S. Moselhy, Magda I. Mohamad, et al.
Annals of Hematology (2025)
Open Access
Chimeric Antigen Receptor Cell Therapy: Empowering Treatment Strategies for Solid Tumors
Tang‐Her Jaing, Yi-Wen Hsiao, Yi-Lun Wang
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 2, pp. 90-90
Open Access
Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapy
Anna De Lucia, L. Mazzotti, Anna Gaimari, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Tri-specific tribodies targeting 5T4, CD3, and immune checkpoint drive stronger functional T-cell responses than combinations of antibody therapeutics
Margherita Passariello, Lorenzo Manna, Rosa Rapuano Lembo, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
The Application and Molecular Mechanisms of Mitochondria-Targeted Antioxidants in Chemotherapy-Induced Cardiac Injury
Chih-Jen Liu, Lu‐Kai Wang, Fu‐Ming Tsai
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 3, pp. 176-176
Open Access
Myeloid-Derived Suppressor Cells: Implications in Cancer Immunology and Immunotherapy
Juan F. Santibáñez
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 3
Open Access
Advances in Gene Therapy with Oncolytic Viruses and CAR-T Cells and Therapy-Related Groups
Yasunari Matsuzaka, Ryu Yashiro
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 4, pp. 268-268
Open Access
ReCARving the future: bridging CAR T-cell therapy gaps with synthetic biology, engineering, and economic insights
Alaa M. Ali, John F. DiPersio
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Regulatory T-cells: The Face-off of the Immune Balance
Mahmoud Singer, Ahmed M. Elsayed, Mohamed I. Husseiny
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 11
Open Access | Times Cited: 4
Armoring chimeric antigen receptor (CAR) T cells as micropharmacies for cancer therapy
C Carcopino, Ergun Erdoğan, M Henrich, et al.
Immuno-Oncology Technology (2024) Vol. 24, pp. 100739-100739
Open Access | Times Cited: 1
Solid cancer-directed CAR T-cell therapy that attacks both tumor and immunosuppressive cells via targeting PD-L1
Yan Luo, Martha E. Gadd, Yaqing Qie, et al.
Deleted Journal (2024) Vol. 32, Iss. 4, pp. 200891-200891
Closed Access | Times Cited: 1
Research Progress on Reshaping the Tumor Immune Microenvironment to Enhance the Effectiveness of Immunotherapy
水恬 井
Advances in Clinical Medicine (2024) Vol. 14, Iss. 09, pp. 858-868
Closed Access
Checkpoint therapy in cancer treatment: progress, challenges, and future directions
Mesude Bicak, Cansu Cimen Bozkus, Nina Bhardwaj
Journal of Clinical Investigation (2024) Vol. 134, Iss. 18
Open Access
Optimising CAR T therapy for the treatment of solid tumors
Norhan Mobark, Caroline Hull, John Maher
Expert Review of Anticancer Therapy (2024), pp. 1-17
Open Access
Page 1

Scroll to top